Picture of Passage Bio logo

PASG — Passage Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Passage Bio To Present Updated Interim Data From Imagine-1 Study For Gm1 Gangliosidosis At 19Th Annual Worldsymposium™ 2023

Feb 15 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO TO PRESENT UPDATED INTERIM DATA FROM IMAGINE-1
STUDY
FOR GM1 GANGLIOSIDOSIS AT 19TH ANNUAL WORLDSYMPOSIUM™ 2023

Source text for Eikon:  ID:nGNX4MPnlk 
Further company coverage:  PASG.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Passage Bio

See all news